The STAT3-Ser/Hes3 signaling axis: An emerging regulator of endogenous regeneration and cancer growth

Frontiers in Physiology

Volumn 4 OCT, Issue , 2013, Pages

  Poser, Steven W ^a   Park, Deric M ^b   Androutsellis Theotokis, Andreas ^a,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Hes3; Regenerative medicine; Signal transduction; STAT3 transcription factor; Stem cells

Indexed keywords

ANGIOPOIETIN RECEPTOR; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; INSULIN; INSULIN RECEPTOR; JANUS KINASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; SERINE; SIGNALOSOME; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HES; TRANSCRIPTION FACTOR HES3; TRANSCRIPTION FACTOR HEY; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ISCHEMIA; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL SURVIVAL; DEGENERATIVE DISEASE; GENE; GENE ACTIVATION; GLIOBLASTOMA; HES GENE; HEY GENE; HUMAN; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSCRIPTION REGULATION;

EID: 84885361397     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00273     Document Type: Article

References (77)

1. Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., et al. (2009). Signal transducer and activator of transcription-3, inflammation, and cancer:how intimate is the relationship? Ann. N.Y. Acad. Sci. 1171, 59-76. doi:10.1111/j.1749-6632.2009.04911.x.
2. Ahn, S., and Joyner, A. L. (2005). In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 437, 894-897. doi:10.1038/nature03994.
3. Allen, T., and Lobe, C. G. (1999). A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. Cell. Mol. Biol. (Noisy-le-grand) 45, 687-708.
4. Altman, J., and Das, G. D. (1965). Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124, 319-335. doi:10.1002/cne.901240303.
5. Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823-826. doi:10.1038/nature04940.
6. Androutsellis-Theotokis, A., Murase, S., Boyd, J. D., Park, D. M., Hoeppner, D. J., Ravin, R., et al. (2008a). Generating neurons from stem cells. Methods Mol. Biol. 438, 31-38. doi:10.1007/978-1-59745-133-8_4.
7. Androutsellis-Theotokis, A., Rueger, M. A., Mkhikian, H., Korb, E., and McKay, R. D. (2008b). Signaling pathways controlling neural stem cells slow progressive brain disease. Cold Spring Harb. Symp. Quant. Biol. 73, 403-410. doi:10.1101/sqb.2008.73.018.
8. Androutsellis-Theotokis, A., Rueger, M. A., Park, D. M., Mkhikian, H., Korb, E., Poser, S. W., et al. (2009). Targeting neural precursors in the adult brain rescues injured dopamine neurons. Proc. Natl. Acad. Sci. U.S.A. 106, 13570-13575. doi:10.1073/pnas.0905125106.
9. Androutsellis-Theotokis, A., Rueger, M. A., Park, D. M., Boyd, J. D., Padmanabhan, R., Campanati, L., et al. (2010a). Angiogenic factors stimulate growth of adult neural stem cells. PLoS ONE 5:e9414. doi:10.1371/journal.pone.0009414.
10. Androutsellis-Theotokis, A., Walbridge, S., Park, D. M., Lonser, R. R., and McKay, R. D. (2010b). Cholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brains. PLoS ONE 5:e10841. doi:10.1371/journal.pone.0010841.
11. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999). Notch signaling:cell fate control and signal integration in development. Science 284, 770-776. doi:10.1126/science.284.5415.770.
12. Banerjee, S., Byrd, J. N., Gianino, S. M., Harpstrite, S. E., Rodriguez, F. J., Tuskan, R. G., et al. (2010). The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo. Cancer Res. 70, 1356-1366. doi:10.1158/0008-5472.CAN-09-2178.
13. Basak, O., and Taylor, V. (2007). Identification of self-replicating multipotent progenitors in the embryonic nervous system by high Notch activity and Hes5 expression. Eur. J. Neurosci. 25, 1006-1022. doi:10.1111/j.1460-9568.2007.05370.x.
14. Basak, O., and Taylor, V. (2009). Stem cells of the adult mammalian brain and their niche. Cell. Mol. Life Sci. 66, 1057-1072. doi:10.1007/s00018-008-8544-x.
15. Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D. A., Rozovsky, I., et al. (1997). Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483. doi:10.1126/science.278.5337.477.
16. Camporeale, A., and Poli, V. (2012). IL-6, IL-17 and STAT3:a holy trinity in auto-immunity? Front. Biosci. (Landmark Ed.) 17, 2306-2326. doi:10.2741/4054.
17. Chung, J., Uchida, E., Grammer, T. C., and Blenis, J. (1997). STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17, 6508-6516.
18. Decker, T., and Kovarik, P. (2000). Serine phosphorylation of STATs. Oncogene 19, 2628-2637. doi:10.1038/sj.onc.1203481.
19. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer:the next generation. Cell 144, 646-674. doi:10.1016/j.cell.2011.02.013.
20. Hatakeyama, J., Bessho, Y., Katoh, K., Ookawara, S., Fujioka, M., Guillemot, F., et al. (2004). Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 131, 5539-5550. doi:10.1242/dev.01436.
21. Hellstrom, M., Phng, L. K., and Gerhardt, H. (2007). VEGF and Notch signaling:the yin and yang of angiogenic sprouting. Cell Adh. Migr. 1, 133-136. doi:10.4161/cam.1.3.4978.
22. Hirata, H., Tomita, K., Bessho, Y., and Kageyama, R. (2001). Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain. EMBO J. 20, 4454-4466. doi:10.1093/emboj/20.16.4454.
23. Imayoshi, I., and Kageyama, R. (2011). The role of Notch signaling in adult neurogenesis. Mol. Neurobiol. 44, 7-12. doi:10.1007/s12035-011-8186-0.
24. Kageyama, R., Ohtsuka, T., Hatakeyama, J., and Ohsawa, R. (2005). Roles of bHLH genes in neural stem cell differentiation. Exp. Cell Res. 306, 343-348. doi:10.1016/j.yexcr.2005.03.015.
25. Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., and Gotoh, Y. (2004). Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6, 547-554. doi:10.1038/ncb1138.
26. Kim, J. H., Yoon, M. S., and Chen, J. (2009). Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation. J. Biol. Chem. 284, 35425-35432. doi:10.1074/jbc. M109.051516.
27. Kittappa, R., Bornstein, S. R., and Androutsellis-Theotokis, A. (2012). The role of eNSCs in neurodegenerative disease. Mol. Neurobiol. 46, 555-562. doi:10.1007/s12035-012-8303-8.
28. Kovarik, P., Stoiber, D., Eyers, P. A., Menghini, R., Neininger, A., Gaestel, M., et al. (1999). Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 96, 13956-13961. doi:10.1073/pnas.96.24.13956.
29. Lacreusette, A., Barbieux, I., Nguyen, J. M., Pandolfino, M. C., Dreno, B., Jacques, Y., et al. (2009). Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells. J. Pathol. 217, 665-676. doi:10.1002/path.2490.
30. Lafave, L. M., and Levine, R. L. (2012). JAK2 the future:therapeutic strategies for JAK-dependent malignancies. Trends Pharmacol. Sci. 33, 574-582. doi:10.1016/j.tips.2012.08.005.
31. Levy, D. E., and Darnell, J. E. Jr. (2002). Stats:transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651-662. doi:10.1038/nrm909.
32. Lim, C. P., and Cao, X. (1999). Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 274, 31055-31061. doi:10.1074/jbc.274.43.31055.
33. Lobe, C. G. (1997). Expression of the helix-loop-helix factor, Hes3, during embryo development suggests a role in early midbrain-hindbrain patterning. Mech. Dev. 62, 227-237. doi:10.1016/S0925-4773(97)00665-5.
34. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., et al. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60. doi:10.1126/science.277.5322.55.
35. Masjkur, J., Rueger, M. A., Bornstein, S. R., McKay, R., and Androutsellis-Theotokis, A. (2012). Neurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vessels. CNS Neurol. Disord. Drug Targets 11, 805-817. doi:10.2174/1871527311201070805.
36. Miyakoshi, M., Yamamoto, M., Tanaka, H., and Ogawa, K. (2012). Serine 727 phosphorylation of STAT3:an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine. Mol. Carcinog. doi:10.1002/mc.21949. [Epub ahead of print].
37. Mohr, A., Chatain, N., Domoszlai, T., Rinis, N., Sommerauer, M., Vogt, M., et al. (2012). Dynamics and non-canonical aspects of JAK/STAT signalling. Eur. J. Cell Biol. 91, 524-532. doi:10.1016/j.ejcb.2011.09.005.
38. Ng, J., and Cantrell, D. (1997). STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J. Biol. Chem. 272, 24542-24549. doi:10.1074/jbc.272.39.24542.
39. Ng, Y. P., Cheung, Z. H., and Ip, N. Y. (2006). STAT3 as a downstream mediator of Trk signaling and functions. J. Biol. Chem. 281, 15636-15644. doi:10.1074/jbc. M601863200.
40. Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., et al. (2006). Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037. doi:10.1038/nature05355.
41. O'shea, J. J., and Plenge, R. (2012). JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542-550. doi:10.1016/j.immuni.2012.03.014.
42. Pacioni, S., Rueger, M. A., Nistico, G., Bornstein, S. R., Park, D. M., McKay, R. D., et al. (2012). Fast, potent pharmacological expansion of endogenous hes3+/sox2+ cells in the adult mouse and rat hippocampus. PLoS ONE 7:e51630. doi:10.1371/journal.pone.0051630.
43. Panchision, D. M., and McKay, R. D. (2002). The control of neural stem cells by morphogenic signals. Curr. Opin. Genet. Dev. 12, 478-487. doi:10.1016/S0959-437X(02)00329-5.
44. Park, D. M., Jung, J., Masjkur, J., Makrogkikas, S., Ebermann, D., Saha, S., et al. (2013). Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics. Sci. Rep. 3:1095. doi:10.1038/srep01095.
45. Plaza-Menacho, I., van der Sluis, T., Hollema, H., Gimm, O., Buys, C. H., Magee, A. I., et al. (2007). Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. J. Biol. Chem. 282, 6415-6424. doi:10.1074/jbc. M608952200.
46. Poser, S. W., Alisky, J., Chung, K.-F., Ebermann, D., Ehrhart-Borsntein, M., Bornstein, S., et al. (2011). "Stem cell growth as a model of carcinogenesis," in Cancer Stem Cells-The Cutting Edge, ed S. Shostak (Rijeka, Croatia:InTech Europe), 89-110.
47. Poser, S. W., and Androutsellis-Theotokis, A. (2013). Growing neural stem cells from conventional and non-conventional regions of the adult rodent brain. J. Vis. Exp. (in press).
48. Qin, H. R., Kim, H. J., Kim, J. Y., Hurt, E. M., Klarmann, G. J., Kawasaki, B. T., et al. (2008). Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res. 68, 7736-7741. doi:10.1158/0008-5472.CAN-08-1125.
49. Rajan, P., and McKay, R. D. (1998). Multiple routes to astrocytic differentiation in the CNS. J Neurosci. 18, 3620-3629.
50. Reich, N. C. (2009). STAT3 revs up the powerhouse. Sci. Signal. 2:pe61. doi:10.1126/scisignal.290pe61.
51. Richard, A. J., and Stephens, J. M. (2011). Emerging roles of JAK-STAT signaling pathways in adipocytes. Trends Endocrinol. Metab. 22, 325-332. doi:10.1016/j.tem.2011.03.007.
52. Rueger, M. A., Backes, H., Walberer, M., Neumaier, B., Ullrich, R., Simard, M. L., et al. (2010). Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J. Neurosci. 30, 6454-6460. doi:10.1523/JNEUROSCI.6092-09.2010.
53. Sasai, Y., Kageyama, R., Tagawa, Y., Shigemoto, R., and Nakanishi, S. (1992). Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 6, 2620-2634. doi:10.1101/gad.6.12b.2620.
54. Sekine, Y., Suzuki, K., and Remaley, A. T. (2011). HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. Prostate 71, 690-699. doi:10.1002/pros.21285.
55. Shen, Y., Schlessinger, K., Zhu, X., Meffre, E., Quimby, F., Levy, D. E., et al. (2004). Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24, 407-419. doi:10.1128/MCB.24.1.407-419.2004.
56. Shimojo, H., Ohtsuka, T., and Kageyama, R. (2011). Dynamic expression of notch signaling genes in neural stem/progenitor cells. Front Neurosci 5:78. doi:10.3389/fnins.2011.00078.
57. Shulga, N., and Pastorino, J. G. (2012). GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J. Cell. Sci. 125, 2995-3003. doi:10.1242/jcs.103093.
58. Siekmann, A. F., and Lawson, N. D. (2007). Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445, 781-784. doi:10.1038/nature05577.
59. Stark, G. R., and Darnell, J. E. Jr. (2012). The JAK-STAT pathway at twenty. Immunity 36, 503-514. doi:10.1016/j.immuni.2012.03.013.
60. Stephens, J. M., Lumpkin, S. J., and Fishman, J. B. (1998). Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J. Biol. Chem. 273, 31408-31416. doi:10.1074/jbc.273.47.31408.
61. Su, L., Rickert, R. C., and David, M. (1999). Rapid STAT phosphorylation via the B cell receptor. Modulatory role of CD19. J. Biol. Chem. 274, 31770-31774. doi:10.1074/jbc.274.45.31770.
62. Swiatek-Machado, K., and Kaminska, B. (2013). STAT signaling in glioma cells. Adv. Exp. Med. Biol. 986, 189-208. doi:10.1007/978-94-007-4719-7_10.
63. Tan, S. L., Ohtsuka, T., Gonzalez, A., and Kageyama, R. (2012). MicroRNA9 regulates neural stem cell differentiation by controlling Hes1 expression dynamics in the developing brain. Genes Cells 17, 952-961. doi:10.1111/gtc.12009.
64. Thurston, G., Noguera-Troise, I., and Yancopoulos, G. D. (2007). The Delta paradox:DLL4 blockade leads to more tumour vessels but less tumour growth. Nat. Rev. Cancer 7, 327-331. doi:10.1038/nrc2130.
65. Tibes, R., Bogenberger, J. M., Geyer, H. L., and Mesa, R. A. (2012). JAK2 inhibitors in the treatment of myeloproliferative neoplasms. Expert Opin. Investig. Drugs 21, 1755-1774. doi:10.1517/13543784.2012.721352.
66. Tkach, M., Rosemblit, C., Rivas, M. A., Proietti, C. J., Diaz Flaque, M. C., Mercogliano, M. F., et al. (2013). p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocr. Relat. Cancer 20, 197-212. doi:10.1530/ERC-12-0194.
67. Ueo, T., Imayoshi, I., Kobayashi, T., Ohtsuka, T., Seno, H., Nakase, H., et al. (2012). The role of Hes genes in intestinal development, homeostasis and tumor formation. Development 139, 1071-1082. doi:10.1242/dev.069070.
68. Vera, J., Rateitschak, K., Lange, F., Kossow, C., Wolkenhauer, O., and Jaster, R. (2011). Systems biology of JAK-STAT signalling in human malignancies. Prog. Biophys. Mol. Biol. 106, 426-434. doi:10.1016/j.pbiomolbio.2011.06.013.
69. Villalva, C., Martin-Lanneree, S., Cortes, U., Dkhissi, F., Wager, M., Le Corf, A., et al. (2011). STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas:a potential for targeted therapy? Int. J. Cancer 28, 826-838. doi:10.1002/ijc.25416.
70. Wauman, J., and Tavernier, J. (2011). Leptin receptor signaling:pathways to leptin resistance. Front. Biosci. (Landmark Ed.) 16, 2771-2793. doi:10.2741/3885.
71. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248. doi:10.1038/35025215.
72. Yang, F., Zhang, W., Li, D., and Zhan, Q. (2013). Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway. J. Biol. Chem. 288, 6552-6560. doi:10.1074/jbc. M112.418335.
73. Yeh, H. H., Giri, R., Chang, T. Y., Chou, C. Y., Su, W. C., and Liu, H. S. (2009). Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell. DNA Cell Biol. 28, 131-139. doi:10.1089/dna.2008.0762.
74. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. (2000). Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10, 47-50. doi:10.1016/S0960-9822(99)00268-7.
75. Zhang, J., Yang, J., Roy, S. K., Tininini, S., Hu, J., Bromberg, J. F., et al. (2003). The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc. Natl. Acad. Sci. U.S.A. 100, 9342-9347. doi:10.1073/pnas.1633516100.
76. Zhou, L., and Too, H. P. (2011). Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS ONE 6:e21680. doi:10.1371/journal.pone.0021680.
77. Zouein, F. A., Zgheib, C., Hamza, S., Fuseler, J. W., Hall, J. E., Soljancic, A., et al. (2013). Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertens. Res. 36, 496-503. doi:10.1038/hr.2012.223.